Work & Mother has opened its latest location in downtown Houston. Photo courtesy of Work & Mother

As companies roll out back-to-work plans for the new year, one subset of workers' needs might be overlooked: new, breastfeeding mothers. However, one Houston startups is looking out for them with a new downtown location.

Work & Mother Services LLC creates and manages a suite of breastfeeding rooms and support equipment — along with a booking smartphone app, and has officially opened its new suite at Three Allen Center. The new facility has 10 private rooms, each equipped with a hospital grade pump, milk storage bags and other supplies; cleaning and sanitizing stations; lockers; refrigeration options; and more.

Work & Mother takes a professional and spa-like approach to a daily, usually dreaded task new moms take on, while also allowing the employer a chance to provide its employees a necessary amenity.

"Pumping at work has always been incredibly hard for mothers. Now, with the pandemic, there are the added complications of germ spread, closed community spaces, and repurposed wellness rooms, which makes pumping at work nearly impossible. Yet, most employers still have a legal obligation to provide a proper space for nursing mothers," says Abbey Donnell, founder and CEO of Work & Mother, in a news release.

Per the Fair Labor Standards Act Section 7(r), companies with 50 or more employees are required to provide "a place, other than a bathroom, that is shielded from view and free from intrusion from coworkers and the public, which may be used by an employee to express breast milk." Companies that aren't in compliance with Section 7(r) — and lack the resources to do so — can either purchase individual or company memberships to Work & Mother.

Brookfield Properties, which is the management company over Allen Center, has now helped its tenants have access to a facility that will help them be compliant.

"Brookfield Properties is deeply committed to creating highly amenitized work environments for our tenants," says Travis Overall, executive vice president and head of the Texas Region for Brookfield Properties. "We have a strong presence of working mothers at the Allen Center campus, which requires thoughtfully curated wellness amenities, such as Work & Mother. We look forward to having this valuable resource readily available for our working mothers once it opens."

Work & Mother has opened other locations downtown, including one at 712 Main St., but the new location at Three Allen Center, designed by PDR Corp., is the latest.

"It's been a great experience to partner with Brookfield Properties on this project, it's clear that they truly care about their tenants. The space at Allen Center is a beautiful, professional amenity that enables working mothers of the buildings and surrounding area to pump safely and with dignity," says Donnell.

Next year, Work & Mother plans to open its first non-Houston location in Austin.

Private rooms

Photo courtesy of Work & Mother

The new facility in Three Allen Center has 10 private rooms, and mothers can book on the Work & Mother app.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”